Chapeau, @Joep de Ligt! That's quite an achievement. It seems like OncoAct is provided as a service to physicians, i. e. run as a medical device exclusively inside the health institution Hartwig Foundation, is that correct?
It seems like certain human intervention is built into the medical device: "This report was generated automatically and checked by a trained Clinical Molecular Biologist in Pathology (KMBP)." This prevents it probably from being marketed as a stand-alone medical device?
Did you have to limit compatibility statements to certain instruments and reference genomes?
(apologies for my very specific questions, but I have always been impressed by the Hartwig Foundation's projects)